You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
桂林三金(002275.SZ):目前公司正積極開展二線獨家產品的市場推廣試點
格隆匯 07-21 10:25

格隆匯7月21日丨有投資者向桂林三金(002275.SZ)提問:二線品種未來的增長和期望,重點有哪些品種?

桂林三金回覆:二線品種以公司獨家特色為主,本次員工持股計劃針對二線品種的考核是引導與側重的,其中產品眩暈寧實現了過億的銷售額,前年是眩暈寧片和眩暈寧顆粒總和過億,去年實現了眩暈寧片單劑型過億,我們還要逐步擴大銷量,從醫學逐步過渡到OTC,達到量級的突破,二線品種上一線品種。其他二線品種如腦脈泰、蛤蚧定喘膠囊等,療效顯著,市場開發潛力大,目前公司正積極開展二線獨家產品的市場推廣試點,探索醫療終端學術推廣模式,加快電商終端建設,以期實現銷量的快速增長,謝謝。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account